Boston Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.75M | Sell |
107,973
-13,228
| -11% | -$1.02M | 0.01% | 445 |
|
|
2025
Q4 | $9.62M | Buy |
121,201
+16,710
| +16% | +$1.32M | 0.01% | 429 |
|
|
2025
Q3 | $7.02M | Buy |
104,491
+56,296
| +117% | +$3.86M | 0.01% | 444 |
|
|
2025
Q2 | $2.76M | Buy |
+48,195
| New | +$3.16M | ﹤0.01% | 520 |
|
|
2025
Q1 | – | Sell |
-6,669
| Closed | -$299K | – | 715 |
|
|
2024
Q4 | $299K | Sell |
6,669
-722
| -10% | -$40.5K | ﹤0.01% | 688 |
|
|
2024
Q3 | $465K | Sell |
7,391
-57
| -0.8% | -$3.33K | ﹤0.01% | 679 |
|
|
2024
Q2 | $440K | Sell |
7,448
-25,647
| -77% | -$1.6M | ﹤0.01% | 671 |
|
|
2024
Q1 | $2.64M | Sell |
33,095
-19,873
| -38% | -$1.52M | ﹤0.01% | 477 |
|
|
2023
Q4 | $4.18M | Sell |
52,968
-24,211
| -31% | -$1.72M | 0.01% | 429 |
|
|
2023
Q3 | $5.39M | Sell |
77,179
-6,471,018
| -99% | -$459M | 0.01% | 411 |
|
|
2023
Q2 | $454M | Sell |
6,548,197
-577,775
| -8% | -$41.1M | 0.61% | 50 |
|
|
2023
Q1 | $529M | Sell |
7,125,972
-1,580,051
| -18% | -$132M | 0.73% | 38 |
|
|
2022
Q4 | $809M | Buy |
8,706,023
+671,235
| +8% | +$64.8M | 1.09% | 17 |
|
|
2022
Q3 | $767M | Buy |
8,034,788
+1,077,638
| +15% | +$107M | 1.12% | 13 |
|
|
2022
Q2 | $645M | Buy |
6,957,150
+200,337
| +3% | +$19.6M | 0.9% | 23 |
|
|
2022
Q1 | $684M | Buy |
6,756,813
+70,329
| +1% | +$7.39M | 0.83% | 30 |
|
|
2021
Q4 | $690M | Buy |
6,686,484
+1,895,954
| +40% | +$175M | 0.83% | 28 |
|
|
2021
Q3 | $406M | Buy |
4,790,530
+233,174
| +5% | +$19.5M | 0.52% | 61 |
|
|
2021
Q2 | $380M | Buy |
4,557,356
+946,028
| +26% | +$77.5M | 0.48% | 65 |
|
|
2021
Q1 | $272M | Sell |
3,611,328
-70,152
| -2% | -$5.11M | 0.36% | 94 |
|
|
2020
Q4 | $251M | Buy |
3,681,480
+2,656,101
| +259% | +$173M | 0.39% | 81 |
|
|
2020
Q3 | $59.9M | Sell |
1,025,379
-158,260
| -13% | -$9.85M | 0.11% | 210 |
|
|
2020
Q2 | $76.9M | Sell |
1,183,639
-142,892
| -11% | -$9M | 0.14% | 184 |
|
|
2020
Q1 | $78.7M | Sell |
1,326,531
-6,295,805
| -83% | -$420M | 0.16% | 167 |
|
|
2019
Q4 | $566M | Sell |
7,622,336
-613,227
| -7% | -$43.1M | 0.75% | 38 |
|
|
2019
Q3 | $520M | Sell |
8,235,563
-504,136
| -6% | -$29.9M | 0.7% | 42 |
|
|
2019
Q2 | $476M | Sell |
8,739,699
-1,525,348
| -15% | -$82.1M | 0.62% | 45 |
|
|
2019
Q1 | $554M | Sell |
10,265,047
-2,117,690
| -17% | -$131M | 0.73% | 35 |
|
|
2018
Q4 | $811M | Buy |
12,382,737
+932,601
| +8% | +$69.6M | 1.17% | 12 |
|
|
2018
Q3 | $901M | Buy |
11,450,136
+1,541,248
| +16% | +$110M | 1.05% | 18 |
|
|
2018
Q2 | $638M | Buy |
9,908,888
+2,924,875
| +42% | +$193M | 0.76% | 33 |
|
|
2018
Q1 | $434M | Sell |
6,984,013
-790,152
| -10% | -$56.7M | 0.52% | 56 |
|
|
2017
Q4 | $564M | Buy |
7,774,165
+266,372
| +4% | +$19.4M | 0.66% | 38 |
|
|
2017
Q3 | $611M | Buy |
7,507,793
+1,048,556
| +16% | +$82.9M | 0.75% | 29 |
|
|
2017
Q2 | $520M | Buy |
6,459,237
+2,638,888
| +69% | +$208M | 0.66% | 39 |
|
|
2017
Q1 | $300M | Sell |
3,820,349
-559,955
| -13% | -$44.7M | 0.38% | 92 |
|
|
2016
Q4 | $346M | Sell |
4,380,304
-94,045
| -2% | -$7.61M | 0.45% | 75 |
|
|
2016
Q3 | $398M | Buy |
4,474,349
+1,456,835
| +48% | +$138M | 0.56% | 51 |
|
|
2016
Q2 | $289M | Sell |
3,017,514
-266,898
| -8% | -$26.6M | 0.42% | 78 |
|
|
2016
Q1 | $341M | Sell |
3,284,412
-590,248
| -15% | -$57.4M | 0.5% | 60 |
|
|
2015
Q4 | $379M | Sell |
3,874,660
-1,111,971
| -22% | -$109M | 0.54% | 54 |
|
|
2015
Q3 | $481M | Sell |
4,986,631
-3,087,594
| -38% | -$325M | 0.73% | 35 |
|
|
2015
Q2 | $847M | Sell |
8,074,225
-575,291
| -7% | -$58.8M | 1.22% | 13 |
|
|
2015
Q1 | $893M | Sell |
8,649,516
-558,525
| -6% | -$56.5M | 1.33% | 11 |
|
|
2014
Q4 | $887M | Sell |
9,208,041
-691,499
| -7% | -$60.9M | 1.33% | 13 |
|
|
2014
Q3 | $788M | Buy |
9,899,540
+650,559
| +7% | +$51.3M | 1.28% | 13 |
|
|
2014
Q2 | $697M | Buy |
9,248,981
+675,294
| +8% | +$51M | 1.17% | 15 |
|
|
2014
Q1 | $642M | Buy |
8,573,687
+773,065
| +10% | +$54.6M | 1.17% | 14 |
|
|
2013
Q4 | $558M | Buy |
7,800,622
+2,963,869
| +61% | +$190M | 1.14% | 15 |
|
|
2013
Q3 | $274M | Buy |
4,836,753
+922,799
| +24% | +$55M | 0.66% | 36 |
|
|
2013
Q2 | $224M | Buy |
+3,913,954
| New | +$227M | 0.62% | 45 |
|
Other funds holding CVS
VCM
VPM
Boston Partners's CVS Position: Q1 2026 in Review
Boston Partners reduced its CVS Health (CVS) stake by 11% in Q1 2026, selling an estimated $1.02M and leaving 107,973 shares worth $7.75M. The position accounts for 0.01% of the portfolio, ranked #445.
Boston Partners first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $901M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Boston Partners held 107,973 shares of CVS Health worth $7.75M as of Q1 2026.
- Boston Partners sold 13,228 CVS Health shares in Q1 2026, an estimated $1.02M.
- CVS Health made up 0.01% of Boston Partners's portfolio in Q1 2026, its #445 holding.
- Boston Partners first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
- Boston Partners's CVS Health position peaked at $901M in Q3 2018.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.